Unresectable Transitional Cell Carcinoma

1 clinical trials · Condition

Record	Firm	Date
Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery (NCT02420847)	M.D. Anderson Cancer Center	2015-07-03

Every clearance here is in the API, with alerts when new ones post.